Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nailesh Bhatt Insider Profile
4 Followers
Nailesh Bhatt, Director at Sonnet BioTherapeutics Holdings, holds 30.73K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN). Most recently, Nailesh Bhatt Bought $25,000 shares of Sonnet BioTherapeutics Holdings on May 18, 2023 for an estimated value of 5.75K.
Nailesh Bhatt has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Nailesh Bhatt holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 18, 2023 - Today
Return:-73.20%
The most profitable trade made by Nailesh Bhatt
Nailesh Bhatt's Trading History
List of latest transactions for each holding click on a transaction to see Nailesh Bhatt's performance on stock
You May Also Like
Nailesh Bhatt insider profile FAQ
What is the percentage of profitable transactions made by Nailesh Bhatt?
The percentage of profitable transactions made by Nailesh Bhatt is ―.
What is the average return per transaction made by Nailesh Bhatt?
The average return per transaction made by Nailesh Bhatt is ―.
What stocks does Nailesh Bhatt hold?
Nailesh Bhatt holds: SONN stocks.
What was Nailesh Bhatt’s latest transaction?
Nailesh Bhatt latest transaction was an Informative Buy of $5.75K.
What was Nailesh Bhatt's most profitable transaction?
Nailesh Bhatt’s most profitable transaction was an Informative Buy of SONN stock on May 18, 2023. The return on the trade was -73.20%.
What is Nailesh Bhatt's role in Sonnet BioTherapeutics Holdings?
Nailesh Bhatt's role in Sonnet BioTherapeutics Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.